炎症体
炎症
促炎细胞因子
生物
细胞生物学
丝状蛋白
角质形成细胞
小干扰RNA
免疫学
化学
转染
基因
细胞培养
生物化学
遗传学
特应性皮炎
作者
Shuai Shao,Zhen Sun,Meng-Fei Chu,Jiaoling Chen,Tianyu Cao,William R. Swindell,Yaxing Bai,Q. Li,Jingyi Ma,Zhenlai Zhu,Andrew Schuler,Yolanda Helfrich,Allison C. Billi,Zhiguo Li,Junfeng Hao,Cheng Xiao,Erle Dang,Jóhann E. Guðjónsson,Gang Wang
摘要
Abstract Background Skin barrier dysfunction may both initiate and aggravate skin inflammation. However, the mechanisms involved in the inflammation process remain largely unknown. Objectives We sought to determine how skin barrier dysfunction enhances skin inflammation and molecular mechanisms. Methods Skin barrier defect mice were established by tape stripping or topical use of acetone on wildtype mice, or filaggrin deficiency. RNA-Seq was employed to analyse the differentially expressed genes in mice with skin barrier defects. Primary human keratinocytes were transfected with formylpeptide receptor (FPR)1 or protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) small interfering RNA to examine the effects of these gene targets. The expressions of inflammasome NOD-like receptor (NLR)C4, epidermal barrier genes and inflammatory mediators were evaluated. Results Mechanical (tape stripping), chemical (acetone) or genetic (filaggrin deficiency) barrier disruption in mice amplified the expression of proinflammatory genes, with transcriptomic profiling revealing overexpression of formylpeptide receptor (Fpr1) in the epidermis. Treatment with the FPR1 agonist fMLP in keratinocytes upregulated the expression of the NLRC4 inflammasome and increased interleukin-1β secretion through modulation of ER stress via the PERK-eIF2α-C/EBP homologous protein pathway. The activation of the FPR1-NLRC4 axis was also observed in skin specimens from old healthy individuals with skin barrier defect or elderly mice. Conversely, topical administration with a FPR1 antagonist, or Nlrc4 silencing, led to the normalization of barrier dysfunction and alleviation of inflammatory skin responses in vivo. Conclusions In summary, our findings show that the FPR1-NLRC4 inflammasome axis is activated upon skin barrier disruption and may explain exaggerated inflammatory responses that are observed in disease states characterized by epidermal dysfunction. Pharmacological inhibition of FPR1 or NLRC4 represents a potential therapeutic target.
科研通智能强力驱动
Strongly Powered by AbleSci AI